Cancer Care

Riverside Brings Research and Cancer Clinical Trials Right to Our Communities

A clinical trial is a research study to determine whether a new drug, treatment, combination of drugs, medical device or procedure is safe and effective. Participation is voluntary and helps doctors and researchers find better ways to prevent, treat or diagnose diseases. Some clinical trials test new ways to treat a disease, while others test new methods of prevention or detection of a disease.

All cancer treatments and therapies used today are available because others agreed to participate in clinical trials in the past.

Our dedicated Cancer Clinical Research team is here to help connect you with a clinical research trial that meets your personalized needs.

 

Open Enrollments for Clinical Research Trials and Research Studies 

Expand the list of clinical trials and research studies open for enrollment at Riverside Cancer Care Network, listed by cancer type.

“Connect” The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)

The purpose of the Connect® MDS/AML Disease Registry is to provide unique insights into treatment regimens and sequencing of these regimens as they relate to clinical outcomes of patients with newly diagnosed Myelodysplastic Syndrome (MDS), Idiopathic Cytopenia of Undetermined Significance (ICUS) or Acute Myeloid Leukemia (AML) in routine clinical practice and evaluate molecular and cellular markers that may provide further prognostic classification and/or might be predictive of therapy outcomes.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.) 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


COMPASS-HER2 _A011801: The COMPASSHER2 Residual Disease Trial A Double-Blinded, Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib 

Breast Cancer

This study is being done to answer the following question: Is the combination of T-DM1 and a newer drug tucatinib, better than usual treatment with T-DM1 alone in preventing breast cancer from returning? We are doing this study because we want to find out if this approach is better or worse than the usual approach for breast cancer.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.)

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

Triple Negative Breast Cancer Riverside Observational Study 012013 - An observational study of triple negative breast cancer at a Community Hospital 

Breast Cancer

The goal of this study is to collect information on how patients who have triple negative breast cancer present with the illness, and how they respond to the treatments they receive. There will be no changes to the treatment you will receive from your doctor. This study will not require you to undergo any specific treatment, tests or evaluations. Information regarding the history of your breast cancer, results of tests and treatments done will be collected from your medical record by the research staff. Twice a year for the duration of the study, updated information concerning your status and any intervening treatments will be collected.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


Anal Cancer Study- EA2176: A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients .

Colorectal Cancer

The purpose of the EA2176 study is to compare chemotherapy alone (this is the standard treatment for metastatic anal cancer) to chemotherapy plus immunotherapy (nivolumab). Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. This study will help the study doctors find out if chemotherapy plus immunotherapy helps reduce symptoms and stop your cancer from growing. 

Colorectal Cancer

For patients with colorectal cancer undergoing surgery regardless of the stage of disease, this circulating tumor DNA biomarker may potentially identify patients who would benefit the most from systemic adjuvant (additional) treatment, even in the absence of other clinical features traditionally considered high-risk. However, use of circulating tumor DNA technology is limited by the absence of prospective data for demonstrating benefit as a predictive biomarker for adjuvant chemotherapy.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.) 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

PROACC-1 Weight loss with Cancer Study_C3651003: Study to evaluate the efficacy, safety and tolerability of Ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15 .

Non-Small Cell Lung Cancer, Pancreatic, Colorectal Cancer

Clinical trial for people that have unexplained weight loss associated with non-small cell lung cancer, pancreatic cancer or colorectal cancer, and no other reason for weight loss. This study will help us learn if an investigational or study drug can treat symptoms related to unexplained weight loss in people with these cancers compared to a placebo.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


OVERT Ovarian Cancer Clinical trial _AOA Dx: non-invasive blood test to assess the likelihood of ovarian malignancy

Ovarian Cancer

An ovarian cancer research trial to evaluate the effectiveness of a new blood test for the early detection of ovarian cancer. AOA Dx has identified a selection of blood markers that have been linked to Ovarian Cancer. By collecting the blood of women with signs and symptoms of ovarian cancer, AOA Dx can evaluate the accuracy of the markers for the early detection of the disease.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.) 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

PROACC-1 Weight loss with Cancer Study_C3651003: Study to evaluate the efficacy, safety and tolerability of Ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15 .

Non-Small Cell Lung Cancer, Pancreatic, Colorectal Cancer

Clinical trial for people that have unexplained weight loss associated with non-small cell lung cancer, pancreatic cancer or colorectal cancer, and no other reason for weight loss. This study will help us learn if an investigational or study drug can treat symptoms related to unexplained weight loss in people with these cancers compared to a placebo.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


PROACC-1 Weight loss with Cancer Study_C3651003: Study to evaluate the efficacy, safety and tolerability of Ponsegromab compared to placebo in patients with cancer, cachexia, and elevated GDF 15 .

Non-Small Cell Lung Cancer, Pancreatic, Colorectal Cancer

This study aims to obtain much needed data to guide oncologists as to the optimal management of patients over the age of 70 with newly diagnosed metastatic Pancreatic cancer. The study design is novel in the use of a carefully designed screening geriatric assessment to select patients for this trial.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.) 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.


Why Participate In A Clinical Research Trial?

  • Access to medicines and therapies that are not on the market yet
  • The research team becomes a part of your health care team
  • Additional services, including imaging, not covered by insurance may be included
  • Qualified participants will receive all study-related care at no charge, including physician examinations, laboratory services, imaging services and study related medications.
  • Participants play a key role in drug development and discovery, helping other people who need treatment in the future

Is My Personal Information Protected? Yes.

  • An informed consent form explaining the details of the trial and your participation will be reviewed with you prior to participation
  • Your medical records are confidential and can only be accessed by the research team, health care providers and the FDA

What If I Enrolled And Changed My Mind?

A participant can leave a clinical trial research study at any time.

How Do I Enroll In A Clinical Research Trial?

If you would like to learn more about clinical trials or research studies available, our clinical research specialists are available to answer any questions and talk with you about opportunities that are fitting for you and your type of cancer.

You may reach our Cancer Clinical Research team by calling 757-534-6890 or send an email to [email protected].

How Do I Know If A Clinical Research Trial is Right For Me?

Opportunities to participate in clinical research are open to everyone.

Talk with your health care provider about your options. Your participation could shape the future of cancer treatment and therapies benefitting you and others.

Before joining a clinical trial, volunteers must meet certain criteria. The factors that allow someone to participate in a clinical trial are called “inclusion criteria” and those that disallow someone to participate in a clinical trial are called “exclusion criteria.”

Criteria is unique to each study, and can include factors such as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. This inclusion and exclusion criteria are used to identify appropriate participants, promote safety, and ensure that researchers learn the information specific to the study.

Types Of Clinical Trials

Treatment Trials - Test new or different approaches to treatment

Prevention Trials - Focus on preventing a disease or stopping a disease from returning

Screening Studies -Test to find the best ways to detect a disease or condition

Quality of Life Studies - Evaluate the effects of treatments on comfort and quality of life

Post Surveillance Studies - Follows the effects of an approved therapy after widespread use

Meet Our Cancer Clinical Research Team

Meagan Gualtiere, BSN, RNMeagan Gualtiere, BSN, RN

Clinical Research Coordinator

Research coordinators are primarily responsible for study coordination and data management, with specialty focus on managing the care of research participants. In addition to providing coordinating clinical care, research coordinators have a central role in assuring participant safety, ongoing maintenance of study activities, integrity of protocol and accuracy of data collection and information recording and follow up.

 

Katie Blomgren, RN, CRCKatie Blomgren, RN, CRC

Clinical Research Coordinator

Research coordinators are primarily responsible for study coordination and data management, with specialty focus on managing the care of research participants. In addition to providing coordinating clinical care, research coordinators have a central role in assuring participant safety, ongoing maintenance of study activities, integrity of protocol and accuracy of data collection and information recording and follow up.

Casey Morris, BACasey Morris, BA

Research Regulatory Coordinator

Supports clinical research team by facilitating the protocol approval process, maintaining regulatory information, and ensuring compliance with regulatory affairs, coordinating study related activities and maintaining research policies and procedures.

 

About Riverside Cancer Care Network

When you choose Riverside for cancer care, you and your loved ones are supported by the power of a network of expertise, where care is delivered close to home – with compassion. Fully accredited as an Integrated Cancer Network Program by the American College of Surgeons Commission on Cancer, we offer the strength of nationally recognized treatment standards, research protocols, educational guidelines and an ongoing focus on comprehensive quality care.

Riverside’s cancer clinical research team carefully adheres to the Commission on Cancer requirements on all cancer research studies. The Commission on Cancer provides accreditation to Riverside for our cancer program and our oncology research activities. Our team follows the National Comprehensive Cancer Network Guidelines looking at all treatment pathways to give each patient the most substantial opportunity for success.

Riverside’s Cancer Clinical Research team participate in Riverside Cancer Care Network tumor boards that bring oncology physicians, practitioners and clinicians from specialties across the health system together to discuss personalized treatment options for cancer patients. During the discussion considerations for clinical trial opportunities are presented.